IBDEI1X1 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,30596,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30596,1,2,0)
;;=2^Ferumoxytol,Non-ESRD,1 MG
;;^UTILITY(U,$J,358.3,30596,1,3,0)
;;=3^Q0138
;;^UTILITY(U,$J,358.3,30597,0)
;;=Q0139^^122^1573^8^^^^1
;;^UTILITY(U,$J,358.3,30597,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30597,1,2,0)
;;=2^Ferumoxytol,ESRD Use,1 MG
;;^UTILITY(U,$J,358.3,30597,1,3,0)
;;=3^Q0139
;;^UTILITY(U,$J,358.3,30598,0)
;;=J1580^^122^1573^10^^^^1
;;^UTILITY(U,$J,358.3,30598,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30598,1,2,0)
;;=2^Garamycin Gentamicin up to 80 MG
;;^UTILITY(U,$J,358.3,30598,1,3,0)
;;=3^J1580
;;^UTILITY(U,$J,358.3,30599,0)
;;=J1644^^122^1573^12^^^^1
;;^UTILITY(U,$J,358.3,30599,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30599,1,2,0)
;;=2^Heparin Sodium per 1000 Units
;;^UTILITY(U,$J,358.3,30599,1,3,0)
;;=3^J1644
;;^UTILITY(U,$J,358.3,30600,0)
;;=96374^^122^1573^13^^^^1
;;^UTILITY(U,$J,358.3,30600,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30600,1,2,0)
;;=2^IV Push,Ther/Proph/Diag
;;^UTILITY(U,$J,358.3,30600,1,3,0)
;;=3^96374
;;^UTILITY(U,$J,358.3,30601,0)
;;=J1750^^122^1573^14^^^^1
;;^UTILITY(U,$J,358.3,30601,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30601,1,2,0)
;;=2^Iron Dextran 50 MG
;;^UTILITY(U,$J,358.3,30601,1,3,0)
;;=3^J1750
;;^UTILITY(U,$J,358.3,30602,0)
;;=B4189^^122^1573^15^^^^1
;;^UTILITY(U,$J,358.3,30602,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30602,1,2,0)
;;=2^Parenteral NutrSol 10-15 g Protein
;;^UTILITY(U,$J,358.3,30602,1,3,0)
;;=3^B4189
;;^UTILITY(U,$J,358.3,30603,0)
;;=J3370^^122^1573^16^^^^1
;;^UTILITY(U,$J,358.3,30603,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30603,1,2,0)
;;=2^Vancomycin HCL 500 MG
;;^UTILITY(U,$J,358.3,30603,1,3,0)
;;=3^J3370
;;^UTILITY(U,$J,358.3,30604,0)
;;=J0882^^122^1573^3^^^^1
;;^UTILITY(U,$J,358.3,30604,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30604,1,2,0)
;;=2^Darbepoetin Alfa,ESRD Use,1 MCG
;;^UTILITY(U,$J,358.3,30604,1,3,0)
;;=3^J0882
;;^UTILITY(U,$J,358.3,30605,0)
;;=J0881^^122^1573^4^^^^1
;;^UTILITY(U,$J,358.3,30605,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30605,1,2,0)
;;=2^Darbepoetin Alfa,Non-ESRD,1 MCG
;;^UTILITY(U,$J,358.3,30605,1,3,0)
;;=3^J0881
;;^UTILITY(U,$J,358.3,30606,0)
;;=J0885^^122^1573^7^^^^1
;;^UTILITY(U,$J,358.3,30606,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30606,1,2,0)
;;=2^Epoetin Alfa,Non-ESRD,1000 Units
;;^UTILITY(U,$J,358.3,30606,1,3,0)
;;=3^J0885
;;^UTILITY(U,$J,358.3,30607,0)
;;=J1642^^122^1573^11^^^^1
;;^UTILITY(U,$J,358.3,30607,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30607,1,2,0)
;;=2^Heparin Sodium per 10 Units
;;^UTILITY(U,$J,358.3,30607,1,3,0)
;;=3^J1642
;;^UTILITY(U,$J,358.3,30608,0)
;;=Q4081^^122^1573^6^^^^1
;;^UTILITY(U,$J,358.3,30608,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30608,1,2,0)
;;=2^Epoetin Alfa,ESRD Use,100 Units
;;^UTILITY(U,$J,358.3,30608,1,3,0)
;;=3^Q4081
;;^UTILITY(U,$J,358.3,30609,0)
;;=92950^^122^1574^5^^^^1
;;^UTILITY(U,$J,358.3,30609,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30609,1,2,0)
;;=2^Heart/Lung Resuscitation CPR
;;^UTILITY(U,$J,358.3,30609,1,3,0)
;;=3^92950
;;^UTILITY(U,$J,358.3,30610,0)
;;=93224^^122^1574^3^^^^1
;;^UTILITY(U,$J,358.3,30610,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,30610,1,2,0)
;;=2^ECG Monitor < 48hrs,Intrp & Rpt
;;^UTILITY(U,$J,358.3,30610,1,3,0)
;;=3^93224
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1X1 3770 printed Apr 09, 2024@21:26:55 Page 2
IBDEI1X1 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,30596,1,0)
+2 ;;=^358.31IA^3^2
+3 ;;^UTILITY(U,$J,358.3,30596,1,2,0)
+4 ;;=2^Ferumoxytol,Non-ESRD,1 MG
+5 ;;^UTILITY(U,$J,358.3,30596,1,3,0)
+6 ;;=3^Q0138
+7 ;;^UTILITY(U,$J,358.3,30597,0)
+8 ;;=Q0139^^122^1573^8^^^^1
+9 ;;^UTILITY(U,$J,358.3,30597,1,0)
+10 ;;=^358.31IA^3^2
+11 ;;^UTILITY(U,$J,358.3,30597,1,2,0)
+12 ;;=2^Ferumoxytol,ESRD Use,1 MG
+13 ;;^UTILITY(U,$J,358.3,30597,1,3,0)
+14 ;;=3^Q0139
+15 ;;^UTILITY(U,$J,358.3,30598,0)
+16 ;;=J1580^^122^1573^10^^^^1
+17 ;;^UTILITY(U,$J,358.3,30598,1,0)
+18 ;;=^358.31IA^3^2
+19 ;;^UTILITY(U,$J,358.3,30598,1,2,0)
+20 ;;=2^Garamycin Gentamicin up to 80 MG
+21 ;;^UTILITY(U,$J,358.3,30598,1,3,0)
+22 ;;=3^J1580
+23 ;;^UTILITY(U,$J,358.3,30599,0)
+24 ;;=J1644^^122^1573^12^^^^1
+25 ;;^UTILITY(U,$J,358.3,30599,1,0)
+26 ;;=^358.31IA^3^2
+27 ;;^UTILITY(U,$J,358.3,30599,1,2,0)
+28 ;;=2^Heparin Sodium per 1000 Units
+29 ;;^UTILITY(U,$J,358.3,30599,1,3,0)
+30 ;;=3^J1644
+31 ;;^UTILITY(U,$J,358.3,30600,0)
+32 ;;=96374^^122^1573^13^^^^1
+33 ;;^UTILITY(U,$J,358.3,30600,1,0)
+34 ;;=^358.31IA^3^2
+35 ;;^UTILITY(U,$J,358.3,30600,1,2,0)
+36 ;;=2^IV Push,Ther/Proph/Diag
+37 ;;^UTILITY(U,$J,358.3,30600,1,3,0)
+38 ;;=3^96374
+39 ;;^UTILITY(U,$J,358.3,30601,0)
+40 ;;=J1750^^122^1573^14^^^^1
+41 ;;^UTILITY(U,$J,358.3,30601,1,0)
+42 ;;=^358.31IA^3^2
+43 ;;^UTILITY(U,$J,358.3,30601,1,2,0)
+44 ;;=2^Iron Dextran 50 MG
+45 ;;^UTILITY(U,$J,358.3,30601,1,3,0)
+46 ;;=3^J1750
+47 ;;^UTILITY(U,$J,358.3,30602,0)
+48 ;;=B4189^^122^1573^15^^^^1
+49 ;;^UTILITY(U,$J,358.3,30602,1,0)
+50 ;;=^358.31IA^3^2
+51 ;;^UTILITY(U,$J,358.3,30602,1,2,0)
+52 ;;=2^Parenteral NutrSol 10-15 g Protein
+53 ;;^UTILITY(U,$J,358.3,30602,1,3,0)
+54 ;;=3^B4189
+55 ;;^UTILITY(U,$J,358.3,30603,0)
+56 ;;=J3370^^122^1573^16^^^^1
+57 ;;^UTILITY(U,$J,358.3,30603,1,0)
+58 ;;=^358.31IA^3^2
+59 ;;^UTILITY(U,$J,358.3,30603,1,2,0)
+60 ;;=2^Vancomycin HCL 500 MG
+61 ;;^UTILITY(U,$J,358.3,30603,1,3,0)
+62 ;;=3^J3370
+63 ;;^UTILITY(U,$J,358.3,30604,0)
+64 ;;=J0882^^122^1573^3^^^^1
+65 ;;^UTILITY(U,$J,358.3,30604,1,0)
+66 ;;=^358.31IA^3^2
+67 ;;^UTILITY(U,$J,358.3,30604,1,2,0)
+68 ;;=2^Darbepoetin Alfa,ESRD Use,1 MCG
+69 ;;^UTILITY(U,$J,358.3,30604,1,3,0)
+70 ;;=3^J0882
+71 ;;^UTILITY(U,$J,358.3,30605,0)
+72 ;;=J0881^^122^1573^4^^^^1
+73 ;;^UTILITY(U,$J,358.3,30605,1,0)
+74 ;;=^358.31IA^3^2
+75 ;;^UTILITY(U,$J,358.3,30605,1,2,0)
+76 ;;=2^Darbepoetin Alfa,Non-ESRD,1 MCG
+77 ;;^UTILITY(U,$J,358.3,30605,1,3,0)
+78 ;;=3^J0881
+79 ;;^UTILITY(U,$J,358.3,30606,0)
+80 ;;=J0885^^122^1573^7^^^^1
+81 ;;^UTILITY(U,$J,358.3,30606,1,0)
+82 ;;=^358.31IA^3^2
+83 ;;^UTILITY(U,$J,358.3,30606,1,2,0)
+84 ;;=2^Epoetin Alfa,Non-ESRD,1000 Units
+85 ;;^UTILITY(U,$J,358.3,30606,1,3,0)
+86 ;;=3^J0885
+87 ;;^UTILITY(U,$J,358.3,30607,0)
+88 ;;=J1642^^122^1573^11^^^^1
+89 ;;^UTILITY(U,$J,358.3,30607,1,0)
+90 ;;=^358.31IA^3^2
+91 ;;^UTILITY(U,$J,358.3,30607,1,2,0)
+92 ;;=2^Heparin Sodium per 10 Units
+93 ;;^UTILITY(U,$J,358.3,30607,1,3,0)
+94 ;;=3^J1642
+95 ;;^UTILITY(U,$J,358.3,30608,0)
+96 ;;=Q4081^^122^1573^6^^^^1
+97 ;;^UTILITY(U,$J,358.3,30608,1,0)
+98 ;;=^358.31IA^3^2
+99 ;;^UTILITY(U,$J,358.3,30608,1,2,0)
+100 ;;=2^Epoetin Alfa,ESRD Use,100 Units
+101 ;;^UTILITY(U,$J,358.3,30608,1,3,0)
+102 ;;=3^Q4081
+103 ;;^UTILITY(U,$J,358.3,30609,0)
+104 ;;=92950^^122^1574^5^^^^1
+105 ;;^UTILITY(U,$J,358.3,30609,1,0)
+106 ;;=^358.31IA^3^2
+107 ;;^UTILITY(U,$J,358.3,30609,1,2,0)
+108 ;;=2^Heart/Lung Resuscitation CPR
+109 ;;^UTILITY(U,$J,358.3,30609,1,3,0)
+110 ;;=3^92950
+111 ;;^UTILITY(U,$J,358.3,30610,0)
+112 ;;=93224^^122^1574^3^^^^1
+113 ;;^UTILITY(U,$J,358.3,30610,1,0)
+114 ;;=^358.31IA^3^2
+115 ;;^UTILITY(U,$J,358.3,30610,1,2,0)
+116 ;;=2^ECG Monitor < 48hrs,Intrp & Rpt
+117 ;;^UTILITY(U,$J,358.3,30610,1,3,0)
+118 ;;=3^93224
